by John A. Jenkins | Nov 26, 2024 | Corporate Investigators, FOIA, Hedge Funds, Law Firms, Litigation, News Media, Politics, SEC
FOIAengine: Requests Signaled Trouble for Guatam Adani Guatam Adani, India’s most powerful tycoon and a close ally of Prime Minister Narendra Modi, knows what it’s like to stare death in the face and survive. Danger has a knack for finding him. But each time – a...
by John A. Jenkins | Oct 31, 2024 | FDA, FOIA, Law Firms, Litigation
FOIAengine: Hundreds of Requests About FDA’s Tobacco Regulation With cigarette makers battling for market dominance in a “smoke-free future,” legal and marketing battles are raging – and recent Freedom of Information Act requests may signal what’s coming next. Womble...
by Randy E. Miller | Oct 24, 2024 | FDA, FOIA, Law Firms, Litigation
FOIAengine: Questions from Siri & Glimstad Point to Possible Litigation Does radiation from cell phones and cell towers affect human health? There has long been controversy around this question, which the federal government has tried to put to rest by issuing...
by John A. Jenkins | Aug 14, 2024 | FOIA, Litigation, News Media, SEC, Short-Selling
FOIAengine: How the “Bounty Hunter of Wall Street” Hedged His Bets As a young man, Andrew Left was a “real serious kid” – and very religious. He wanted to be a rabbi. But then, in his telling, Left saw a newspaper ad that said, “Earn $100,000.” “I thought, ‘Yeah,...
by John A. Jenkins | Jul 10, 2024 | FOIA, Hedge Funds, Litigation, SEC
FOIA Requests Reveal Perils and Possibilities of the Consolidated Audit Trail, aka “Mass Surveillance” Imagine a time when anyone might be able to file a Freedom of Information Act request with the Securities and Exchange Commission for a complete audit-trail report...
by Randy E. Miller | Jul 3, 2024 | FDA, FOIA, Law Firms, Litigation, Pharmaceuticals
FOIAengine: Law Firm’s 48 Inquiries Follow Earlier Requests Personal injury law firm Morgan & Morgan continued to push the Food and Drug Administration during May for documents that could strengthen potential litigation challenging popular weight control drugs. ...
